BSEM Stock Summary and Trading Ideas (Biostem Technologies | NASDAQ:BSEM)

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

What symbol and exchange does Biostem Technologies shares trade?

Biostem Technologies trades on the NASDAQ stock market under the symbol BSEM.

What is Biostem Technologies stock price doing today?

As of October 16, 2026, BSEM stock price climbed to $2.10 with 17,541 million shares trading.

How much is Biostem Technologies worth?

BSEM has a market cap of $39.21 million. This is considered a Sub-Micro Cap stock.

What are the top ETFs holding Biostem Technologies?

The top ETF exchange traded funds that BSEM belongs to (by Net Assets): VTI, VXF.

What are the support and resistance levels for Biostem Technologies (BSEM)?

BSEM support price is $1.86 and resistance is $2.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BSEM shares will trade within this expected range on the day.